L Wilson1, C Szabó, A L Salzman. 1. Division of Critical Care, Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Abstract
BACKGROUND & AIMS: Nuclear translocation of the NF-kappaB family of transcription factors is a proximal step in the signal transduction of a pleiotropic group of proinflammatory genes. Activation of RelA is under the negative control of IkappaB, a family of proteins degraded in response to immunologic and oxidant stimuli. The aim of this study was to examine this mechanism of NF-kappaB activation in intestinal epithelial cells. METHODS: DLD-1 cell monolayers stimulated by interleukin (IL)-1beta or phorbol myristate acetate (PMA) were assayed for the nuclear translocation of NF-kappaB and immunoreactivity of various IkappaB isoforms that regulate NF-kappaB1/RelA activation. RESULTS: NF-kappaB activation triggered by PMA was not associated with the disappearance of immunoreactive IkappaBalpha, IkappaBbeta, IkappaBgamma, or IkappaBepsilon or with the dissociation of intact IkappaB from RelA. NF-kappaB activation induced by PMA was blocked by the protein kinase C inhibitor staurosporine but not by the proteasomal inhibitor N-acetyl-leucine leucine norleucinal (ALLN). In contrast, IL-1beta-induced NF-kappaB activation was associated with the disappearance of IkappaBalpha and was inhibited by ALLN but not staurosporine. CONCLUSIONS: Our data imply the existence of a novel pathway of NF-kappaB activation mediated by protein kinase C that does not require proteosomal degradation or the loss of IkappaB.
BACKGROUND & AIMS: Nuclear translocation of the NF-kappaB family of transcription factors is a proximal step in the signal transduction of a pleiotropic group of proinflammatory genes. Activation of RelA is under the negative control of IkappaB, a family of proteins degraded in response to immunologic and oxidant stimuli. The aim of this study was to examine this mechanism of NF-kappaB activation in intestinal epithelial cells. METHODS: DLD-1 cell monolayers stimulated by interleukin (IL)-1beta or phorbol myristate acetate (PMA) were assayed for the nuclear translocation of NF-kappaB and immunoreactivity of various IkappaB isoforms that regulate NF-kappaB1/RelA activation. RESULTS:NF-kappaB activation triggered by PMA was not associated with the disappearance of immunoreactive IkappaBalpha, IkappaBbeta, IkappaBgamma, or IkappaBepsilon or with the dissociation of intact IkappaB from RelA. NF-kappaB activation induced by PMA was blocked by the protein kinase C inhibitor staurosporine but not by the proteasomal inhibitor N-acetyl-leucine leucine norleucinal (ALLN). In contrast, IL-1beta-induced NF-kappaB activation was associated with the disappearance of IkappaBalpha and was inhibited by ALLN but not staurosporine. CONCLUSIONS: Our data imply the existence of a novel pathway of NF-kappaB activation mediated by protein kinase C that does not require proteosomal degradation or the loss of IkappaB.
Authors: M Sen; K Lauterbach; H El-Gabalawy; G S Firestein; M Corr; D A Carson Journal: Proc Natl Acad Sci U S A Date: 2000-03-14 Impact factor: 11.205
Authors: Marybeth A Pysz; Fang Hao; A Asli Hizli; Michelle A Lum; Wendy M Swetzig; Adrian R Black; Jennifer D Black Journal: J Biol Chem Date: 2014-06-09 Impact factor: 5.157